A lens to detect glaucoma
Sensimed, a spin-off of the Swiss Technology Institute of Lausanne (EPFL), has developed a novel solution to monitor intraocular pressure continuously up to 24 hours. Named Triggerfish, those lenses will not only revolutionize the way glaucoma is diagnosed and treatment is performed, but will also make a contribution to a deeper understanding of its progression. For the first time it will allow ophtalmologists to personalise the patient’s treatment and to monitor the efficacy of the treatment.
The solution consists of a soft, non-invasive contact lens which encapsulates a telemetric sensor. The external system consists of an adhesive antenna worn around the eye attached to a portable recording device. Each lens includes a dedicated full custom integrated micro-processor and a battery-powered recorder with embedded application-specific firmware. Sensimed has just closed an extension of its oversubscribed series B round financing with an additional 5 million Swiss francs from Agate Medical Investments LP and 3,5 million francs from New value AG. The additional financing brings the total series B round to 18,6 million francs. [FD]